Australian researchers find same arm for both shots boosts vaccine response
Receiving a vaccine booster in the same arm as the first dose triggers a faster and stronger immune response and helps the body build protection faster, according to new research.
The findings could help improve vaccine strategies and may eventually lead to vaccines that need fewer boosters, Xinhua news agency reported.
The study, which was led by the Garvan Institute of Medical Research and the Kirby Institute at the University of New South Wales (UNSW) Sydney in Australia finds that the immune system responds more quickly when both doses are given in the same arm.
That's because immune cells in nearby lymph nodes, which are the body's infection-fighting hubs, become "primed" after the first shot. When the booster arrives in the same spot, these cells spring into action and help produce stronger antibodies, the team explained in the paper, published in the journal Cell.
Researchers discovered this effect first in mice, then confirmed it in a clinical study involving 30 people who received the Pfizer Covid-19 vaccine. Those who had both doses in the same arm developed faster and more effective protection, especially against Covid-19 variants like Delta and Omicron.
"This is a fundamental discovery in how the immune system organizes itself to respond better to external threats," said Tri Phan, director of the Precision Immunology Programme at the Garvan Institute.
While both groups ended up with similar antibody levels after four weeks, the same-arm group gained protection more quickly, a potential game-changer during pandemic outbreaks.
"If you've had your Covid jabs in different arms, don't worry, our research shows that over time the difference in protection diminishes," said the study's co-senior author Mee Ling Munier from the Kirby Institute.
But during a pandemic, even a few days can make a big difference, said Munier
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
17 minutes ago
- Indian Express
Manipur confirms first Covid case this year as university student tests positive
Manipur confirmed its first Covid case this year after a 23-year-old student tested positive for coronavirus, Health Services Director Dr Chambo Gonmei said on Tuesday. The Covid patient is a native of Ngaikhong Khullen in Bishnupur district and a master's student at Manipur University, Dr Gonmei said. Dr Gonmei said the 23-year-old woman's RT-PCR test returned positive on Monday. He said the patient was tested at a private clinic in Imphal on June 5 after developing Covid symptoms, including fever. However, she left Imphal for Hyderabad for her internship before knowing her Covid status. She has reportedly been staying in a rented apartment in Imphal West district. Dr Gonmei said the state Covid surveillance team was investigating the case. 'Our team has also reached out to the administration in Bishnupur, the native district of the patient, besides Imphal West. We have learned that she had been under home isolation after developing the symptoms,' he said. Dr Gonmei said that although it was waiting for a new advisory from the health ministry, the state health department had taken all the precautionary measures based on the earlier guidelines. Dr Gonmei said there was no need to panic. 'We are investigating the type of the variant. But the public need not panic, for the new strain is not as severe as the previous ones. Only patients with a poor immune system are more vulnerable,' he said. As per official sources, Manipur reported its previous Covid case on May 25, 2024. During the pandemic, 2,149 people died of Covid and over 1.40 lakh people tested positive for the virus in the state.
News18
an hour ago
- News18
XFG: What Is The New Covid Variant Detected In India Amid Rising Cases? Explained
Last Updated: Amid this surge, the new variant of the SARS-CoV-2 was detected with as many as 163 cases reported so far, of which the most are from Maharashtra at 89 India recorded a total of 6,815 active coronavirus cases with three deaths in the last 24 hours. Amid this surge, XFG – a new variant of the SARS-CoV-2 – was detected with as many as 163 cases reported so far. According to data from the Indian SARS-CoV-2 Genomics Consortium (INSACOG), the XFG variant has been found in a total of 163 samples – highest (89) in Maharashtra, followed by Tamil Nadu (16), Kerala (15), Gujarat (11), and Andhra Pradesh, Madhya Pradesh and West Bengal (six each). A RECOMBINANT VARIANT: WHAT DOES THIS MEAN? An article in Lancet stated that the recombinant XFG variant harbours four key spike mutations and has achieved rapid global spread following its initial detection in Canada. Data shows that in May, as many as 159 samples were detected with the XFG variant while two samples were tested for this variant in April and two in June. It is essentially the result of two earlier strains — LF.7 and LP.8.1.2 — merging together. A recombinant variant like XFG emerges when someone is infected with two different versions of the virus at the same time, allowing it to 'mix and match" its genetic code. The Lancet study points out that this variant shows 'strong immune evasion". WHAT IS THE CENTRE DOING? According to the Union health ministry data released on June 8, Kerala continues to be the most affected state, followed by Gujarat, West Bengal and Delhi. Official sources have said due to the rising cases, the Centre is conducting mock drills to check facility-level preparedness and has instructed all states to ensure availability of oxygen, isolation beds, ventilators, and essential medicines. They maintained that most cases are mild and managed under home care. Since January this year, 65 deaths have been reported in the country. There were a total of 257 active patients in the country on May 22. A series of technical review meetings were held on June 2 and 3 under the chairpersonship of Dr Sunita Sharma, Director General of Health Services, to evaluate the Covid situation and preparedness measures. Representatives from the Disaster Management Cell, Emergency Management Response Cell, National Centre for Disease Control, Indian Council of Medical Research, Integrated Disease Surveillance Programme, central government hospitals in Delhi, and all states and Union Territories were part of the meeting. State and district surveillance units under the Integrated Disease Surveillance Programme are closely monitoring Influenza-Like Illness (ILI) and Severe Acute Respiratory Illness (SARI). 'Testing is recommended for all admitted SARI cases and 5 per cent of ILI cases as per guidelines, and positive SARI samples are sent for Whole Genome Sequencing through the ICMR VRDL network, " an official source said. First Published: June 10, 2025, 19:34 IST
&w=3840&q=100)
First Post
2 hours ago
- First Post
Kennedy's decision to fire independent CDC experts sparks fears of vaccine scepticism, experts warn
In a Wall Street Journal column, Kennedy, a long-time vaccine sceptic, said that he was dismissing all 17 members of the Centres for Disease Control and Prevention's Advisory Committee for Immunisation Practices (ACIP) 'to re-establish public confidence in vaccine science' read more Public health professionals and others warned Monday that the dismissal of an independent panel of experts by U.S. Health Secretary Robert F. Kennedy Jr., who cited the purpose of rebuilding trust in vaccinations, might erode confidence in already available vaccines and expose Americans to avoidable infectious illnesses. In a Wall Street Journal column, Kennedy, a long-time vaccine sceptic, said that he was dismissing all 17 members of the Centres for Disease Control and Prevention's Advisory Committee for Immunisation Practices (ACIP) 'to re-establish public confidence in vaccine science.' STORY CONTINUES BELOW THIS AD The committee advises the CDC on the use of vaccinations that have been licensed by the US Food and Drug Administration. 'I fear that there will be human lives lost here because of this,' said Dr. Sean O'Leary, chair of the American Academy of Pediatrics' Committee on Infectious Diseases. 'It is a special kind of irony that he is saying he is doing this to restore trust, given that he is, as an individual, more responsible for sowing distrust in vaccines than almost anyone I can name,' O'Leary said. O'Leary said pediatricians have already been fielding calls from parents who are confused about conflicting announcements earlier this month narrowing the use of COVID-19 vaccines for healthy children and pregnant women. 'This is only going to add to that,' he said. A U.S. Department of Health and Human Services spokesman said the agency is prioritizing public health, evidence-based medicine, and restoring public confidence in vaccine science. The firing of the entire vaccine advisory committee comes just weeks before a scheduled public meeting in which advisers were expected to weigh in and vote on a number of decisions, including the 2025-26 COVID-19 vaccine boosters. The health agency said the committee will meet as scheduled on June 25-27, but it is unclear who would serve on that panel or how they have been vetted for conflicts of interest. The agency said it would replace them with new members currently under consideration. Fired ACIP member Noel Brewer, a professor of public health at the University of North Carolina, said it took about 18 months from the time he applied until he was serving as an ACIP member. STORY CONTINUES BELOW THIS AD Senate Minority Leader Chuck Schumer decried the changes. 'Wiping out an entire panel of vaccine experts doesn't build trust — it shatters it, and worse, it sends a chilling message: that ideology matters more than evidence, and politics more than public health,' he said in a statement. Former CDC Director Dr. Thomas Frieden called out Kennedy's 'false claims' in the Wall Street Journal piece, saying the panel was rife with conflicts of interest. Most of the panel was appointed last year, the CDC website shows. 'Make no mistake: Politicizing the ACIP as Secretary Kennedy is doing will undermine public trust under the guise of improving it.'
